Protalix BioTherapeutics Inc (PLX) is traded on American Stock Exchange in USA. It is located in ISRAEL and employs 223 people. Protalix BioTherapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Micro-Cap
' category with total capitalization of 85.65 M. Protalix BioTherapeutics Inc has 139.73 M outstanding shares of which 0 shares are at this time shorted by investors with about 0.0 days to cover shorted positions.
PROTALIX BIOTHERA has about 33.48 M in cash with (34.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24.
Check Protalix BioTherapeutics Probability Of Bankruptcy